Asset Details
Do you wish to reserve the book?
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity
Do you wish to request the book?
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity
2015
Overview
IgG molecules exert both pro- and antiinflammatory effector functions based on the composition of the fragment crystallizable (Fc) domain glycan. Sialylated IgG Fc domains have antiinflammatory properties that are attributed to their ability to increase the activation threshold of innate effector cells to immune complexes by stimulating the upregulation of the inhibitory Fcγ receptor IIB (FcγRIIB). Here, we report that IgG Fc sialylation of human monoclonal IgG1 molecules impairs their efficacy to induce complement-mediated cytotoxicity (CDC). Fc sialylation of a CD20-targeting antibody had no impact on antibody-dependent cellular cytotoxicity and did not change the affinity of the antibody for activating Fcγ receptors. In contrast, the presence of sialic acid abrogated the increased binding of C1q to Fc-galactosylated IgG1 and resulted in decreased levels of C3b deposition on the cell surface. Similar to monoclonal antibodies, sialic acid inhibited the increased C1q binding to galactosylated Fc fragments in human polyclonal IgG. In sera derived from patients with chronic inflammatory demyelinating polyneuropathy, an autoimmune disease of the peripheral nervous system in which humoral immune responses mediate tissue damage, induction of IgG Fc sialylation was associated with clinical disease remission. Thus, impairment of CDC represents an FcγR-independent mechanism by which Fc-sialylated glycovariants might limit proinflammatory IgG effector functions.
Publisher
American Society for Clinical Investigation
Subject
/ Animals
/ Antibody-Dependent Cell Cytotoxicity
/ Antigens
/ Burkitt Lymphoma - pathology
/ Complement Pathway, Classical
/ Complement System Proteins - immunology
/ Humans
/ Immunoglobulin G - chemistry
/ Immunoglobulin G - immunology
/ Immunoglobulin gamma-Chains - chemistry
/ Immunoglobulin gamma-Chains - immunology
/ Immunoglobulins, Intravenous - therapeutic use
/ Killer Cells, Natural - immunology
/ Lectins
/ Mice
/ Myelin-Oligodendrocyte Glycoprotein - immunology
/ N-Acetylneuraminic Acid - chemistry
/ Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - immunology
/ Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - therapy
/ Protein Processing, Post-Translational
/ Software
We currently cannot retrieve any items related to this title. Kindly check back at a later time.